Plain-English translation of NCT06702579 on ClinicalTrials.gov ↗ · Source last updated ·
Researchers are developing a new device that patients with hemophilia A could use at home to monitor their blood clotting factor levels. This study asks patients and healthcare providers about their experiences with home monitoring — both for hemophilia care and for people taking blood-thinning medications — to understand how this tool could help people manage their condition better.
Many people with hemophilia A currently have to visit hospitals or clinics regularly to check their treatment. Researchers want to know if home monitoring could give patients more control over their care, reduce clinic visits, and help identify what features a home monitoring system should have to truly meet patients' needs.
You would take part in either a one-on-one interview or a small group discussion (focus group) where researchers ask you about your current experience managing hemophilia, your thoughts on home monitoring, and what features would be most helpful to you. The conversation would be recorded and typically last 45–90 minutes. There are no medical procedures, blood tests, or medication involved — it is simply sharing your experiences and opinions.
AI-generated summary from trial data · Jul 2, 2026 · Not medical advice
Netherlands